Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling
暂无分享,去创建一个
Denis Thieffry | Martin Kuiper | Anaïs Baudot | Elisabeth Remy | Astrid Lægreid | Liv Thommesen | Åsmund Flobak | A. Lægreid | M. Kuiper | É. Remy | D. Thieffry | Åsmund Flobak | L. Thommesen | A. Baudot | Å. Flobak | Martin Kuiper
[1] Anushya Muruganujan,et al. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..
[2] Shao-Cong Sun,et al. Non-canonical NF-κB signaling pathway , 2011, Cell Research.
[3] D. Tindall,et al. FOXOs, cancer and regulation of apoptosis , 2008, Oncogene.
[4] Tak W. Mak,et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.
[5] Takeshi Azuma,et al. Helicobacter pylori CagA Induces Ras-independent Morphogenetic Response through SHP-2 Recruitment and Activation* , 2004, Journal of Biological Chemistry.
[6] Bertram Wiedenmann,et al. Oxidative Stress Activates the Human Histidine Decarboxylase Promoter in AGS Gastric Cancer Cells* , 1998, The Journal of Biological Chemistry.
[7] Joshua Wolf,et al. Mitogen-Activated Protein Kinases Promote WNT/β-Catenin Signaling via Phosphorylation of LRP6 , 2010, Molecular and Cellular Biology.
[8] A. Safa,et al. c-FLIP, a master anti-apoptotic regulator. , 2012, Experimental oncology.
[9] K. Nan,et al. CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line , 2013, World Journal of Surgical Oncology.
[10] Tao Zhang,et al. Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling , 2011, Autophagy.
[11] Yang Xie,et al. A community computational challenge to predict the activity of pairs of compounds , 2014, Nature Biotechnology.
[12] J. Paik,et al. FoxO family members in cancer , 2011, Cancer biology & therapy.
[13] Aurélien Naldi,et al. Logical modelling of regulatory networks with GINsim 2.3 , 2009, Biosyst..
[14] Ulrich Keilholz,et al. In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype , 2012, Gastric Cancer.
[15] P. Galle,et al. Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines , 2012, Cancer Chemotherapy and Pharmacology.
[16] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[17] John M. Lambert,et al. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism , 2002, Nature Cell Biology.
[18] N LeNovère. Quantitative and logic modelling of molecular and gene networks. , 2015 .
[19] Konrad Basler,et al. The many faces and functions of β‐catenin , 2012, The EMBO journal.
[20] Susan E. Abbatiello,et al. Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.
[21] Mark D Gustavson,et al. Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters , 2004, Molecular carcinogenesis.
[22] T. Chou,et al. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.
[23] Yi-Chen Liao,et al. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells , 2010, Molecular and Cellular Biochemistry.
[24] S. Park,et al. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase. , 2001, Biochemical and biophysical research communications.
[25] T. Nam,et al. A polysaccharide of the marine alga Capsosiphon fulvescens induces apoptosis in AGS gastric cancer cells via an IGF‐IR‐mediated PI3K/Akt pathway , 2007, Cell biology international.
[26] Kaichun Wu,et al. Inhibition of the p53–MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer , 2009, The journal of gene medicine.
[27] Dianqing Wu,et al. GSK3: a multifaceted kinase in Wnt signaling. , 2010, Trends in biochemical sciences.
[28] Kai Gao,et al. Proteomics analysis of gastric epithelial AGS cells infected with Epstein-Barr virus. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[29] Richie Soong,et al. Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-Fluorouracil in PIK3CA mutant gastric cancer cells , 2012, Cancer biology & therapy.
[30] Yan-Shen Shan,et al. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer. , 2012, Immunobiology.
[31] G. Bae,et al. Constitutive activation of p70S6k in cancer cells , 2002, Archives of pharmacal research.
[32] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[33] D. Guertin,et al. Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy , 2010, Oncogene.
[34] Zhijian J. Chen,et al. Ubiquitination in signaling to and activation of IKK , 2012, Immunological reviews.
[35] Martin Schuler,et al. Targeted therapies in gastroesophageal cancer. , 2014, European journal of cancer.
[36] Nina Jones,et al. Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. , 2012, The Biochemical journal.
[37] W. Greco,et al. The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.
[38] Roopma Wadhwa,et al. Gastric cancer—molecular and clinical dimensions , 2013, Nature Reviews Clinical Oncology.
[39] D. Meek,et al. S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response , 2010, The EMBO journal.
[40] S. Loewe. The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.
[41] M-T Lau,et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells , 2011, Oncogene.
[42] E. Henske,et al. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease , 2005, Oncogene.
[43] J. Voltas,et al. [Treatment of gastric cancer]. , 1982, Revista de medicina de la Universidad de Navarra.
[44] Joseph Avruch,et al. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. , 2012, Physiological reviews.
[45] Kei Sakamoto,et al. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer , 2010, Proceedings of the National Academy of Sciences.
[46] Lin Meng,et al. p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR , 2008, Molecular Cancer Therapeutics.
[47] Yun Yen,et al. Ribonucleotide Reductase Large Subunit M1 Predicts Poor Survival Due to Modulation of Proliferative and Invasive Ability of Gastric Cancer , 2013, PloS one.
[48] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[49] Mahandranauth A. Chetram,et al. PTEN regulation of ERK1/2 signaling in cancer , 2012, Journal of receptor and signal transduction research.
[50] Holger Fröhlich,et al. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance , 2009, BMC Systems Biology.
[51] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[52] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[53] Chia Huey Ooi,et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. , 2011, Gastroenterology.
[54] T. Brabletz,et al. Gastrointestinal stem cells in development and cancer , 2009, The Journal of pathology.
[55] Feng-Lin Chen,et al. 12-Lipoxygenase Induces Apoptosis of Human Gastric Cancer AGS Cells via the ERK1/2 Signal Pathway , 2007, Digestive Diseases and Sciences.
[56] Gary D Bader,et al. NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.
[57] Will Slocombe,et al. Turning the tables. , 2012, Mental health today.
[58] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[59] G. Wahl,et al. MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.
[60] Denis Thieffry,et al. Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Comput. Biol..
[61] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[62] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[63] Subramanian Senthivinayagam,et al. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation. , 2010, Molecular endocrinology.
[64] Sara Baldelli,et al. trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun signalling axis. , 2009, Biochemical pharmacology.
[65] J. Park,et al. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. , 2008, Oncology reports.
[66] S. Ghosh,et al. Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.
[67] Sridhar Ramaswamy,et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer , 2014, Science.
[68] Lincoln Stein,et al. Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..
[69] K. Lan,et al. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model. , 2013, Carcinogenesis.
[70] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[71] W. Bodmer,et al. Cancer cell lines for drug discovery and development. , 2014, Cancer research.
[72] Ye Guang Chen,et al. Dishevelled: The hub of Wnt signaling. , 2010, Cellular signalling.
[73] Mala Sinha,et al. Suppressing Wnt Signaling by the Hedgehog Pathway through sFRP-1* , 2006, Journal of Biological Chemistry.
[74] Pedro T. Monteiro,et al. Dynamical modeling and analysis of large cellular regulatory networks. , 2013, Chaos.
[75] Luke A. Gilbert,et al. Defining principles of combination drug mechanisms of action , 2012, Proceedings of the National Academy of Sciences.
[76] Song Li,et al. Boolean network simulations for life scientists , 2008, Source Code for Biology and Medicine.
[77] Hiroaki Kitano,et al. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .
[78] Julian Downward,et al. RAS Interaction with PI3K: More Than Just Another Effector Pathway. , 2011, Genes & cancer.
[79] Uffe Holmskov,et al. Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. , 2005, Carcinogenesis.
[80] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[81] Aurélien Naldi,et al. Dynamically consistent reduction of logical regulatory graphs , 2011, Theor. Comput. Sci..
[82] Yan Xue,et al. Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. , 2004, Biochemical and biophysical research communications.
[83] J. Bayascas,et al. PDK1: the major transducer of PI 3-kinase actions. , 2010, Current topics in microbiology and immunology.
[84] D. Fingar,et al. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. , 2012, The Biochemical journal.
[85] Susumu Goto,et al. Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..
[86] Chi-Sen Chang,et al. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. , 2013, Toxicology and applied pharmacology.
[87] Ji Hye Kim,et al. Ethanol extract of paeonia suffruticosa Andrews (PSE) induced AGS human gastric cancer cell apoptosis via fas-dependent apoptosis and MDM2-p53 pathways , 2012, Journal of Biomedical Science.
[88] Wei-peng Wang,et al. Effect of PI3K gene silencing on growth, migration and related proteins expression of CD40 signal-mediated gastric cancer cells , 2012, Molecular Biology Reports.
[89] L. Hong,et al. Reversal of multidrug resistance of gastric cancer cells by downregulation of CIAPIN1 with CIAPIN1 siRNA , 2008, Molecular Biology.
[90] T. Chou. Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.
[91] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[92] Linheng Li,et al. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. , 2010, Birth defects research. Part C, Embryo today : reviews.
[93] C. Sander,et al. Models from experiments: combinatorial drug perturbations of cancer cells , 2008, Molecular systems biology.
[94] Shiwen Luo,et al. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: a novel mechanism of PTEN inactivation. , 2013, Clinics and research in hepatology and gastroenterology.
[95] Gautam Damera,et al. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway. , 2007, The international journal of biochemistry & cell biology.
[96] Yoshiaki Ito,et al. RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells* , 2006, Journal of Biological Chemistry.
[97] Wei Zhou,et al. LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway. , 2011, World journal of gastroenterology.
[98] A. Braeuning,et al. Mechanisms of RAS/β-catenin interactions , 2013, Archives of Toxicology.
[99] A. Eijkelenboom,et al. FOXOs: signalling integrators for homeostasis maintenance , 2013, Nature reviews. Molecular cell biology.
[100] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[101] P. Sorger,et al. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.
[102] Hiroyuki Takahashi,et al. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas. , 2010, Human pathology.
[103] Cun-Yu Wang,et al. IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways. , 2006, Cellular signalling.
[104] C. McClain,et al. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes , 2005, Cell Death and Differentiation.
[105] S. Kopetz,et al. The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men , 2012, Clinical Cancer Research.
[106] A. Eliopoulos,et al. Tpl2 kinase signal transduction in inflammation and cancer. , 2011, Cancer letters.
[107] J. Blenis,et al. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.
[108] M. Andjelkovic,et al. Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.
[109] Andreas Zell,et al. Path2Models: large-scale generation of computational models from biochemical pathway maps , 2013, BMC Systems Biology.
[110] Vítězslav Bryja,et al. β-Arrestin is a necessary component of Wnt/β-catenin signaling in vitro and in vivo , 2007, Proceedings of the National Academy of Sciences.
[111] F. Chou,et al. Protocatechuic acid inhibits cancer cell metastasis involving the down‐regulation of Ras/Akt/NF‐κB pathway and MMP‐2 production by targeting RhoB activation , 2011, British journal of pharmacology.
[112] Bostjan Kobe,et al. Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases , 2006, Microbiology and Molecular Biology Reviews.
[113] Yu Li,et al. Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK/ERK and JAK2-signaling pathways in gastric cancer cells , 2011, Gastric Cancer.
[114] G. Salvesen,et al. Regulation of the Apaf-1–caspase-9 apoptosome , 2010, Journal of Cell Science.
[115] C. Weston,et al. The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.
[116] J. Hassell,et al. Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer , 2012, PloS one.
[117] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[118] J. Sung,et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer , 2013, Oncogene.
[119] S A Forbes,et al. The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.
[120] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[121] Yeong Shik Kim,et al. Platycodin D induces anoikis and caspase‐mediated apoptosis via p38 MAPK in AGS human gastric cancer cells , 2013, Journal of cellular biochemistry.
[122] Zhen Ge,et al. Discovering differential protein expression caused by CagA-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform. , 2008, World journal of gastroenterology.
[123] Xin Liu,et al. Dynamical and Structural Analysis of a T Cell Survival Network Identifies Novel Candidate Therapeutic Targets for Large Granular Lymphocyte Leukemia , 2011, PLoS Comput. Biol..
[124] A. Dar,et al. The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells , 2008, Oncogene.
[125] Sarat Chandarlapaty,et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. , 2011, Cancer cell.
[126] N. Normanno,et al. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches , 2012, Expert opinion on therapeutic targets.
[127] Jiyong Wang,et al. TAB2 Scaffolds TAK1 and NLK in Repressing Canonical Wnt Signaling* , 2010, The Journal of Biological Chemistry.
[128] Sam Michael,et al. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells , 2014, Proceedings of the National Academy of Sciences.
[129] E Birney,et al. The Genome Knowledgebase: a resource for biologists and bioinformaticists. , 2003, Cold Spring Harbor symposia on quantitative biology.
[130] Bing-Hua Jiang,et al. AKT‐dependent phosphorylation of Niban regulates nucleophosmin‐ and MDM2‐mediated p53 stability and cell apoptosis , 2012, EMBO reports.
[131] J. Goldberg,et al. Helicobacter pylori and mitogen‐activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells , 2008, Journal of gastroenterology and hepatology.
[132] Hui-Hsuan Lin,et al. Apoptotic effect of 3,4‐dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation , 2007, International journal of cancer.
[133] Takao Kawabe,et al. Helicobacter pylori Induces IκB Kinase α Nuclear Translocation and Chemokine Production in Gastric Epithelial Cells , 2006, Infection and Immunity.
[134] Michael D. Cole,et al. c-Myc Transforms Human Mammary Epithelial Cells through Repression of the Wnt Inhibitors DKK1 and SFRP1 , 2007, Molecular and Cellular Biology.
[135] Alfonso Valencia,et al. Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment , 2014, Clinical Cancer Research.
[136] Krishnendu Chatterjee,et al. Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.
[137] J. Blenis,et al. The RSK family of kinases: emerging roles in cellular signalling , 2008, Nature Reviews Molecular Cell Biology.
[138] Susanta Roychoudhury,et al. NF-kappaB Mediated Transcriptional Repression of Acid Modifying Hormone Gastrin , 2013, PloS one.
[139] Eric Chevet,et al. Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer , 2008, Pharmacological Reviews.
[140] J. K. Kundu,et al. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β-catenin signaling , 2012, International journal of oncology.
[141] Sorin V. Sabau,et al. A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth , 2009, BMC Cancer.
[142] Helene Maccario,et al. PTEN is destabilized by phosphorylation on Thr366. , 2007, The Biochemical journal.
[143] Cun-Yu Wang,et al. IKKα stabilizes cytosolic β-catenin by inhibiting both canonical and non-canonical degradation pathways , 2006 .
[144] P. Gama,et al. MAPKs and Signal Transduction in the Control of Gastrointestinal Epithelial Cell Proliferation and Differentiation , 2013, International journal of molecular sciences.
[145] M. Mohammadi,et al. Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling , 2012, Science Signaling.
[146] M. Saegusa,et al. Transcription factor Egr1 acts as an upstream regulator of β‐catenin signalling through up‐regulation of TCF4 and p300 expression during trans‐differentiation of endometrial carcinoma cells , 2008, The Journal of pathology.
[147] Miao Yu,et al. The roles of REIC gene and its encoding product in gastric carcinoma , 2012, Cell cycle.
[148] Yiling Lu,et al. Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. , 2010, Cancer research.
[149] Woo Ick Yang,et al. Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric Adenocarcinoma , 2008, Molecular Cancer Research.
[150] Melanie Boerries,et al. Boolean approach to signalling pathway modelling in HGF-induced keratinocyte migration , 2012, Bioinform..
[151] Tim Beißbarth,et al. Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines , 2014, BMC Systems Biology.
[152] Mark Boothby,et al. Faculty Opinions recommendation of The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. , 2006 .
[153] Bertram Klinger,et al. Network quantification of EGFR signaling unveils potential for targeted combination therapy , 2013, Molecular systems biology.
[154] Oliver Sawodny,et al. Modeling the TNFα-Induced Apoptosis Pathway in Hepatocytes , 2011, PloS one.
[155] Naoto Ueno,et al. The TAK1-NLK Mitogen-Activated Protein Kinase Cascade Functions in the Wnt-5a/Ca2+ Pathway To Antagonize Wnt/β-Catenin Signaling , 2003, Molecular and Cellular Biology.
[156] Jae-Hyun Ryu,et al. Multinuclear giant cell formation is enhanced by down-regulation of Wnt signaling in gastric cancer cell line, AGS. , 2005, Experimental cell research.
[157] Amith Panner,et al. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. , 2010, Cancer research.
[158] R. Albert,et al. Network model of survival signaling in large granular lymphocyte leukemia , 2008, Proceedings of the National Academy of Sciences.
[159] Alexander Hapfelmeier,et al. Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines , 2012, Journal of Cancer Research and Clinical Oncology.
[160] Yiming Huang,et al. Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells , 2010, Cancer biology & therapy.
[161] Thomas A. Miller,et al. Targeting PI3K/Akt/HSP90 Signaling Sensitizes Gastric Cancer Cells to Deoxycholate-Induced Apoptosis , 2011, Digestive Diseases and Sciences.
[162] L. Platanias,et al. The evolution of the TOR pathway and its role in cancer , 2013, Oncogene.
[163] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[164] S H Jang,et al. Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[165] J. McCubrey,et al. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells , 2003, Oncogene.
[166] Sharmila Shankar,et al. Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor , 2008, Journal of molecular signaling.
[167] Min Yu,et al. TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers , 2012, Cell.
[168] Chao-Lin Kuo,et al. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways. , 2010, Anticancer research.
[169] N. Kikuchi,et al. CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks , 2008, Proceedings of the IEEE.
[170] In‑Hye Kim,et al. Capsosiphon fulvescens glycoprotein inhibits AGS gastric cancer cell proliferation by downregulating Wnt-1 signaling , 2013, International journal of oncology.
[171] T. Cotter,et al. Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.
[172] Hans Clevers,et al. Wnt/β-Catenin Signaling and Disease , 2012, Cell.
[173] R. Guo,et al. c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway. , 2012, Cancer letters.
[174] Michael Naumann,et al. Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention , 2012, BMC Systems Biology.
[175] Sunhong Kim,et al. Regulation of FOXO1 by TAK1-Nemo-like Kinase Pathway* , 2010, The Journal of Biological Chemistry.
[176] Nayoung Kim,et al. Anti‐gastric cancer effects of celecoxib, a selective COX‐2 inhibitor, through inhibition of Akt signaling , 2009, Journal of gastroenterology and hepatology.
[177] Kosuke Yanai,et al. Crosstalk of hedgehog and Wnt pathways in gastric cancer. , 2008, Cancer letters.
[178] S. Watson,et al. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7 , 2010, Gut.
[179] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[180] T. Gilmore,et al. Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.
[181] Michael Peyton,et al. Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo , 2010, PloS one.
[182] Xuan Sun,et al. Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.
[183] Rune Linding,et al. Navigating cancer network attractors for tumor-specific therapy , 2012, Nature Biotechnology.
[184] N. Novère. Quantitative and logic modelling of molecular and gene networks , 2015, Nature Reviews Genetics.
[185] G. Pagès,et al. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. , 2010, American journal of physiology. Cell physiology.
[186] E. Henske,et al. Rheb Inhibits C-Raf Activity and B-Raf/C-Raf Heterodimerization* , 2006, Journal of Biological Chemistry.
[187] G. Baldwin,et al. The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway , 2009, Regulatory Peptides.
[188] Xavier Coumoul,et al. Understanding SOS (Son of Sevenless). , 2011, Biochemical pharmacology.
[189] Roland Hartig,et al. Helicobacter pylori activates protein kinase C delta to control Raf in MAP kinase signalling: role in AGS epithelial cell scattering and elongation. , 2009, Cell motility and the cytoskeleton.
[190] Wun-Jae Kim,et al. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[191] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[192] A. Bardelli,et al. Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas , 2012, Clinical Cancer Research.
[193] Sung Hee Jang,et al. The phenyl-thiophenyl propenone RK-I-123 reduces the levels of reactive oxygen species and suppresses the activation of NF-κB and AP-1 and IL-8 expression in Helicobacter pylori-infected gastric epithelial AGS cells , 2013, Inflammation Research.
[194] Stuart A. Aaronson,et al. Diverse Mechanisms of Wnt Activation and Effects of Pathway Inhibition on Proliferation of Human Gastric Carcinoma Cells , 2010, Oncogene.
[195] Thimo Rohlf,et al. Receptor cross-talk in angiogenesis: mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model. , 2010, Journal of theoretical biology.
[196] J. Arthur,et al. Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.
[197] T. Herdegen,et al. The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7. , 2011, European journal of cell biology.
[198] Samuel So,et al. Small molecule antagonists of Tcf4/β‐catenin complex inhibit the growth of HCC cells in vitro and in vivo , 2010, International journal of cancer.
[199] Chris Sander,et al. Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets , 2013, Science Signaling.
[200] David Zhang,et al. The crosstalk between EGF, IGF, and Insulin cell signaling pathways - computational and experimental analysis , 2009, BMC Systems Biology.
[201] B. Vangamudi,et al. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells , 2011, Molecular Cancer.
[202] Hyun Cheol Chung,et al. Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer , 2009, PLoS genetics.
[203] Denis Thieffry,et al. Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement , 2010, PLoS Comput. Biol..
[204] M. Li‐Weber,et al. Helicobacter pylori Activates the Early Growth Response 1 Protein in Gastric Epithelial Cells , 2004, Infection and Immunity.
[205] Astrid Lægreid,et al. Gastrin-induced proliferation involves MEK partner 1 (MP1) , 2013, In Vitro Cellular & Developmental Biology - Animal.
[206] In Sung Song,et al. Effect of Inhibition of Extracellular Signal-Regulated Kinase 1 and 2 Pathway on Apoptosis and bcl-2 Expression in Helicobacter pylori-Infected AGS Cells , 2003, Infection and Immunity.
[207] L. Spagnoli,et al. Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. , 2006, The American journal of pathology.
[208] Wenyan Lu,et al. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. , 2009, European journal of pharmacology.
[209] Jan J. Brosens,et al. Forkhead box proteins: tuning forks for transcriptional harmony. , 2013, Nature reviews. Cancer.
[210] Rui-Sheng Wang,et al. Boolean modeling in systems biology: an overview of methodology and applications , 2012, Physical biology.
[211] René Thomas. Regulatory networks seen as asynchronous automata: A logical description , 1991 .
[212] Debasis Mondal,et al. Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. , 2013, The Journal of surgical research.
[213] Steffen Klamt,et al. Transforming Boolean models to continuous models: methodology and application to T-cell receptor signaling , 2009, BMC Systems Biology.
[214] C. Rinker-Schaeffer,et al. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. , 2008, Cancer letters.
[215] Jon Read,et al. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. , 2013, ACS chemical biology.
[216] Chao-Lin Kuo,et al. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways , 2011, Human & experimental toxicology.
[217] Michael J. Seckl,et al. Specificity The p 90 RSK Family Members : Common Functions and Isoform , 2013 .
[218] Oliver Sawodny,et al. ON/OFF and Beyond - A Boolean Model of Apoptosis , 2009, PLoS Comput. Biol..
[219] M. L. Martins,et al. Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes , 2013, PloS one.
[220] Michael Karin,et al. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. , 2012, Gastroenterology.
[221] Michael Naumann,et al. Helicobacter pylori-induced tyrosine phosphorylation of IKKβ contributes to NF-κB activation , 2011, Biological chemistry.